RPG Life Sciences share news, announcements and annual reports
NSE: RPGLIFEBSE: 532983Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,003.80.
30 Oct: open ₹2,812.00, high ₹2,849.60, low ₹2,513.50
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,260 Cr923rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 38.94
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.20
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.93%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it, the company's own balance sheet from before it began consolidating; the two agree where both are first on record.
- 17.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,38,78323.6% delivered
RPG Life Sciences share news and announcements
681 announcements, routine notices left out, newest first. Page 6 of 14.
Feb 2022
7 Feb · Updates
Jan 2022
25 Jan · Results
25 Jan · Board meeting
18 Jan · Board meeting
Oct 2021
29 Oct · Results
29 Oct · Board meeting
20 Oct · Analysts
18 Oct · Board meeting
Aug 2021
24 Aug · Analysts
5 Aug · Corporate action
Jul 2021
28 Jul · Results
28 Jul · Board meeting
21 Jul · Board meeting
Jun 2021
14 Jun · Analysts
9 Jun · Analysts
May 2021
Apr 2021
30 Apr · Results
30 Apr · Results
30 Apr · Board meeting
27 Apr · Annual Disclosure
23 Apr · Board meeting
21 Apr · Legal
The exchange asked on 20 Apr 2021
Jan 2021
25 Jan · Results
25 Jan · Board meeting
21 Jan · Legal
The exchange asked on 20 Jan 2021
18 Jan · Board meeting
Dec 2020
18 Dec · Rating
Nov 2020
Oct 2020
30 Oct · Results
30 Oct · Board meeting
23 Oct · Board meeting
Sep 2020
Aug 2020
Jul 2020
31 Jul · Updates
31 Jul · Results